Literature DB >> 22022197

Ovarian hyper-response to administration of an GnRH-agonist without gonadotropins.

Hyun Tae Park1, Hyo Sook Bae, Tak Kim, Sun Haeng Kim.   

Abstract

Several case reports have indicated that a small subgroup of patients may develop ovarian hyperstimulation following the administration of gonadotropin-releasing hormone agonists (GnRHa) without gonadotropins. However, since only few such cases have been published, it is unclear what course to follow in subsequent cycles after ovarian hyperstimulation in the first cycle using only GnRHa. A 33-yr-old woman was referred to in vitro fertilization for oocyte donation. A depot preparation (3.75 mg) of tryptorelin without gonadotropins induced ovarian multifollicular enlargement with high estradiol level, and was followed by human chorionic gonadotropin administration and oocyte retrieval. In a subsequent cycle of the same patient, a low dose of tryptorelin (0.05 mg) did not induce ovarian hyperstimulation, and resulted in clinical pregnancy. This report shows potential management of ovarian hyperstimulation following the administration of GnRHa without gonadotropins.

Entities:  

Keywords:  GnRH Agonist; IVF; Ovarian Hyperstimulation

Mesh:

Substances:

Year:  2011        PMID: 22022197      PMCID: PMC3192356          DOI: 10.3346/jkms.2011.26.10.1394

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  11 in total

Review 1.  Follicle selection in primates: "many are called but few are chosen".

Authors:  A J Zeleznik
Journal:  Biol Reprod       Date:  2001-09       Impact factor: 4.285

2.  Direct effect of gonadotropin-releasing hormone agonists on the rabbit ovarian follicle.

Authors:  Y Yoshimura; Y Nakamura; M Ando; S Shiokawa; N Koyama; T Nanno
Journal:  Fertil Steril       Date:  1992-05       Impact factor: 7.329

3.  Ovarian cyst formation following GnRH agonist administration in IVF cycles: incidence and impact.

Authors:  H S Qublan; Z Amarin; Y A Tahat; A Z Smadi; M Kilani
Journal:  Hum Reprod       Date:  2005-10-27       Impact factor: 6.918

4.  Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins.

Authors:  R N Porter; W Smith; I L Craft; N A Abdulwahid; H S Jacobs
Journal:  Lancet       Date:  1984-12-01       Impact factor: 79.321

5.  Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.

Authors:  A J Morales; G A Laughlin; T Bützow; H Maheshwari; G Baumann; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1996-08       Impact factor: 5.958

6.  Modulation of the steroidogenesis of cultured human granulosa-lutein cells by gonadotropin-releasing hormone analogs.

Authors:  I Bussenot; C Azoulay-Barjonet; J Parinaud
Journal:  J Clin Endocrinol Metab       Date:  1993-05       Impact factor: 5.958

7.  Ovarian hyperstimulation following the sole administration of agonistic analogues of gonadotrophin releasing hormone.

Authors:  A Weissman; A Barash; H Shapiro; R F Casper
Journal:  Hum Reprod       Date:  1998-12       Impact factor: 6.918

8.  First live birth following IVF-embryo transfer and use of GnRHa alone for ovarian stimulation.

Authors:  Foad Azem; Beni Almog; Dalit Ben-Yosef; Rita Kapustiansky; Israel Wagman; Ami Amit
Journal:  Reprod Biomed Online       Date:  2009-08       Impact factor: 3.828

9.  Gonadotropin-releasing hormone agonist (leuprolide acetate) induced ovarian hyperstimulation syndrome in a woman undergoing intermittent hemodialysis.

Authors:  H L Hampton; N S Whitworth; B D Cowan
Journal:  Fertil Steril       Date:  1991-02       Impact factor: 7.329

10.  Ovarian hyperstimulation syndrome following the sole administration of injectable gonadotropin-releasing hormone agonist (triptorelin) for the pituitary down-regulation and in vitro fertilization treatment: report of two cases.

Authors:  Hussein S Qublan; Zakarya Beni-Merei; Mohamad Megdadi; Gassan Al-Quraan
Journal:  Arch Gynecol Obstet       Date:  2008-05-07       Impact factor: 2.344

View more
  1 in total

1.  Severe ovarian hyperstimulation syndrome associated with long-acting GnRH agonist in oncofertility patients.

Authors:  Jacob Christ; Christopher N Herndon; Bo Yu
Journal:  J Assist Reprod Genet       Date:  2021-01-20       Impact factor: 3.412

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.